M.D. Sass LLC Boosts Stock Holdings in AMETEK, Inc. $AME

M.D. Sass LLC boosted its position in shares of AMETEK, Inc. (NYSE:AMEFree Report) by 9.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 400,881 shares of the technology company’s stock after purchasing an additional 33,887 shares during the period. AMETEK comprises 5.7% of M.D. Sass LLC’s holdings, making the stock its 5th largest position. M.D. Sass LLC owned approximately 0.17% of AMETEK worth $72,543,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of AME. SouthState Corp grew its holdings in shares of AMETEK by 47.4% during the second quarter. SouthState Corp now owns 202 shares of the technology company’s stock worth $37,000 after buying an additional 65 shares in the last quarter. Signature Estate & Investment Advisors LLC boosted its position in AMETEK by 3.9% during the 1st quarter. Signature Estate & Investment Advisors LLC now owns 1,784 shares of the technology company’s stock worth $307,000 after acquiring an additional 67 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of AMETEK by 3.0% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,335 shares of the technology company’s stock worth $423,000 after acquiring an additional 69 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC raised its holdings in shares of AMETEK by 57.7% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company’s stock valued at $33,000 after purchasing an additional 71 shares during the last quarter. Finally, Federated Hermes Inc. lifted its position in shares of AMETEK by 8.3% in the first quarter. Federated Hermes Inc. now owns 1,017 shares of the technology company’s stock worth $175,000 after purchasing an additional 78 shares in the last quarter. 87.43% of the stock is currently owned by institutional investors.

Insider Buying and Selling at AMETEK

In other news, CEO David A. Zapico sold 88,000 shares of the stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $196.39, for a total value of $17,282,320.00. Following the transaction, the chief executive officer directly owned 348,955 shares of the company’s stock, valued at $68,531,272.45. This represents a 20.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ronald J. Oscher sold 26,290 shares of the firm’s stock in a transaction dated Friday, October 31st. The stock was sold at an average price of $200.05, for a total transaction of $5,259,314.50. Following the sale, the insider owned 40,226 shares of the company’s stock, valued at approximately $8,047,211.30. This represents a 39.52% decrease in their position. The SEC filing for this sale provides additional information. 0.57% of the stock is owned by insiders.

AMETEK Trading Up 0.8%

AMETEK stock opened at $197.89 on Monday. The stock has a 50-day simple moving average of $190.02 and a 200 day simple moving average of $184.77. The stock has a market capitalization of $45.56 billion, a P/E ratio of 31.87, a PEG ratio of 2.64 and a beta of 1.12. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.04 and a current ratio of 1.63. AMETEK, Inc. has a 52 week low of $145.02 and a 52 week high of $204.15.

AMETEK (NYSE:AMEGet Free Report) last released its quarterly earnings data on Thursday, October 30th. The technology company reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.76 by $0.13. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The company had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.81 billion. During the same period last year, the firm posted $1.66 earnings per share. The business’s revenue was up 10.8% on a year-over-year basis. AMETEK has set its Q4 2025 guidance at 1.900-1.950 EPS. FY 2025 guidance at 7.320-7.370 EPS. Analysts expect that AMETEK, Inc. will post 7.15 earnings per share for the current year.

AMETEK Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 19th. Shareholders of record on Friday, December 5th will be issued a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, December 5th. AMETEK’s payout ratio is currently 19.56%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on AME. Truist Financial raised their target price on shares of AMETEK from $219.00 to $229.00 and gave the company a “buy” rating in a research report on Wednesday, October 8th. KeyCorp raised their price objective on AMETEK from $205.00 to $220.00 and gave the company an “overweight” rating in a report on Friday, October 31st. Royal Bank Of Canada upped their target price on AMETEK from $212.00 to $229.00 and gave the stock an “outperform” rating in a report on Friday, October 31st. Weiss Ratings reissued a “buy (b)” rating on shares of AMETEK in a research report on Wednesday, October 8th. Finally, TD Cowen raised AMETEK from a “sell” rating to a “hold” rating and boosted their price target for the stock from $158.00 to $180.00 in a research report on Tuesday, September 2nd. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, AMETEK presently has a consensus rating of “Moderate Buy” and an average target price of $211.00.

Check Out Our Latest Research Report on AMETEK

AMETEK Profile

(Free Report)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Further Reading

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.